Most diabetes stem-cell trials recruit in Asia, the Middle East and Latin America, mixing lower cost with variable oversight. US and EU trials are fewer but adhere to FDA/EMA standards and offer the best safety documentation. For Type 1, US (JDRF-funded) and EU academic trials are the highest-evidence options; for any case, prioritise ClinicalTrials.gov registration and academic sponsorship over commercial clinics.
Indicative European costs are roughly €4,000–€8,000 per course, reflecting cell expansion, purity testing, and frequently multiple infusions. Type 1 protocols may add immune-monitoring; Type 2 protocols often bundle metabolic assessment and follow-up. For context, insulin and monitoring supplies cost roughly €100–€300 monthly and are proven — the stem-cell figure is indicative and unproven.
Съм ли кандидат? → · Diabetes (Type 1 & 2): full overview → · Цена Захарен диабет (Тип 1 & 2) → · Cost →
Медицински преглед от редакционния екип на StemCellAtlas с Dr Polina Krasenova (Haematologist · Clinical Haematology & Integrative Oncology · 15+ yrs cell therapy) на партньорската клиника Stem Plus (София), спрямо ISSCR, FDA и EMA указания. Educational information, not medical advice; figures indicative.
GMP-сертифицирана регенеративна медицина в сърцето на ЕС — от 3 000–8 000 €, част от цените в САЩ или Германия. Персонализирани протоколи за пациенти от над 50 държави.
Безплатна медицинска оценка